Literature DB >> 20805910

Clinical manifestations, diagnosis, and empirical treatments for catatonia.

Mahendra T Bhati1, Catherine J Datto, John P O'Reardon.   

Abstract

OBJECTIVE: Review the medical literature on the history and clinical features of catatonia so as to provide a contemporary clinical guide for successfully diagnosing and treating the various clinical forms of catatonia.
DESIGN: RESULTS of MEDLINE computerized searches using search terms 'catatonia', 'treatment of catatonia', 'electroconvulsive therapy and catatonia', 'benzodiazepines and catatonia', clinical case reports, and book chapters covering the medical and psychiatric literature relevant to catatonia and its associated treatments were examined.
SETTING: Academic medical center. PARTICIPANTS: None. MEASUREMENTS: None.
RESULTS: Catatonia is a common but under-recognized clinical syndrome. No large-scale, controlled studies exist to determine the relative effectiveness of current treatments, including sedative-hypnotic medications (benzodiazepines or barbiturates), and electroconvulsive therapy (ECT).
CONCLUSION: Despite the lack of large-scale, controlled studies, benzodiazepines appear to be an effective first-line treatment for catatonia. ECT is now often reserved as a second-line treatment despite more than 60 years of documented efficacy and safety. However, ECT should be viewed as a first-line intervention in cases of severe or malignant catatonias.

Entities:  

Keywords:  benzodiazepines; catatonia; electroconvulsive therapy; seizures

Year:  2007        PMID: 20805910      PMCID: PMC2922358     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  41 in total

1.  ECT for schizophrenia.

Authors:  P Taylor; J J Fleminger
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

Review 2.  Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.

Authors:  J Greenhalgh; C Knight; D Hind; C Beverley; S Walters
Journal:  Health Technol Assess       Date:  2005-03       Impact factor: 4.014

3.  The differential diagnosis of catatonic states.

Authors:  A Stoudemire
Journal:  Psychosomatics       Date:  1982-03       Impact factor: 2.386

4.  Long-term outcome after ECT for catatonic depression.

Authors:  C M Swartz; V Morrow; L Surles; J F James
Journal:  J ECT       Date:  2001-09       Impact factor: 3.635

5.  Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.

Authors:  John M. Davis; Philip G. Janicak; Paul Sakkas; Cindy Gilmore; Zhengyu Wang
Journal:  Convuls Ther       Date:  1991

6.  Electroconvulsive Therapy of the Lethal Catatonia Syndrome.

Authors:  Stephan C. Mann; Stanley N. Caroff; Henry R. Bleier; R. Eduardo Antelo; Hyong Un
Journal:  Convuls Ther       Date:  1990

7.  Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.

Authors:  G Northoff; J Eckert; J Fritze
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 8.  Somatic treatment of catatonia.

Authors:  J M Hawkins; K J Archer; S M Strakowski; P E Keck
Journal:  Int J Psychiatry Med       Date:  1995       Impact factor: 1.210

9.  ECT in the treatment of the catatonic syndrome.

Authors:  B M Rohland; B T Carroll; R G Jacoby
Journal:  J Affect Disord       Date:  1993-12       Impact factor: 4.839

10.  The first-line use of electroconvulsive therapy in major affective disorders.

Authors:  Barry M Maletzky
Journal:  J ECT       Date:  2004-06       Impact factor: 3.635

View more
  10 in total

1.  The detection and measurement of catatonia.

Authors:  Rob Kirkhart; Niraj Ahuja; Joseph Wy Lee; Jose Ramirez; Rebecca Talbert; Kishwer Faiz; Gabor S Ungvari; Christopher Thomas; Brendan T Carroll
Journal:  Psychiatry (Edgmont)       Date:  2007-09

2.  Regarding catatonia.

Authors:  Brendan T Carroll; Jose Ramirez; Kishwer Faiz; Rob Kirkhart; Christopher Thomas
Journal:  Psychiatry (Edgmont)       Date:  2007-05

3.  Catatonia due to alprazolam withdrawal.

Authors:  Siddharth Iyengar; Charles Bornmann; Farid Abdelmalak; Tulisa LaRocca
Journal:  BMJ Case Rep       Date:  2018-12-14

Review 4.  Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Authors:  Nancy J Butcher; Erik Boot; Anthony E Lang; Danielle Andrade; Jacob Vorstman; Donna McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-05-19       Impact factor: 2.802

Review 5.  Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.

Authors:  Federica Luchini; Pierpaolo Medda; Michela Giorgi Mariani; Mauro Mauri; Cristina Toni; Giulio Perugi
Journal:  World J Psychiatry       Date:  2015-06-22

6.  Management and outcomes of catatonia: A prospective study in urban South Africa.

Authors:  Zukiswa Zingela; Louise Stroud; Johan Cronje; Max Fink; Stephan van Wyk
Journal:  SAGE Open Med       Date:  2022-06-20

7.  Rapid Response of Long-Standing, Treatment-Resistant Non-Catatonic Mutism in Paranoid Schizophrenia with Single ECT session.

Authors:  Mansoor Ahmad Dar; Yasir Hassan Rather; Majid Shafi Shah; Rayees Ahmad Wani; Arshad Hussain
Journal:  N Am J Med Sci       Date:  2014-11

8.  Clinical and demographic profile of catatonic patients who received electroconvulsive therapy in a South African setting.

Authors:  Kavendren Odayar; Ingrid Eloff; Willem Esterhuysen
Journal:  S Afr J Psychiatr       Date:  2018-08-30       Impact factor: 1.550

9.  A prospective descriptive study on prevalence of catatonia and correlates in an acute mental health unit in Nelson Mandela Bay, South Africa.

Authors:  Zukiswa Zingela; Louise Stroud; Johan Cronje; Max Fink; Stephan Van Wyk
Journal:  PLoS One       Date:  2022-03-08       Impact factor: 3.240

10.  Successful Treatment of Catatonia: A Case Report and Review of Treatment.

Authors:  Kevin Malone; Sall Saveen; Christopher M Stevens; Shawn McNeil
Journal:  Cureus       Date:  2022-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.